How it Works

Founded in 1994, Theralase Technologies Inc. designs, develops and manufactures patented, super-pulsed non-thermal laser technology for the safe and effective treatment of a wide range of pain conditions. The technology has been approved by Health Canada, the U.S. Food and Drug Administration (“FDA”) and Conformité Européene (“CE”) for sale in over 172 countries for the safe and effective treatment of chronic knee pain. Theralase technology has been proven scientifically and clinically effective in: eliminating pain, reducing inflammation and accelerating tissue healing in numerous nerve, muscle and joint conditions.

Our next generation TLC-2000 laser with Biofeedback technology automatically adjusts its parameters to deliver the most effective dose of light energy to the exact location of tissue damage for every patient, every time, optimizing their healing bene t and returning patients to peak performance faster.

​

Theralase remains the most scientifically and clinically supported therapeutic medical laser technology on the market. Theralase has partnered with leading research institutes including Toronto’s University Health Network advance our scientific and clinical knowledge of how to best optimize the effects of non-thermal laser technology. 

​

Treatments

Normally a series of treatments are required for best results. Initially 2-3 treatments are required weekly for the first 4-6 weeks. Following the initial 4-6 weeks, one would continue treatment on a weekly or bi-weekly basis depending on the severity of the condition. (Some acute conditions can be gone within 5 sessions of laser treatments, sub-acute approximately 12-15 sessions and chronic can take 20+)